Peer-Reviewed Publication UNIVERSITAT AUTONOMA DE BARCELONA A study by the Institut de Neurociències of the UAB (INc-UAB) demonstrates in animal models the benefits of vorinostat after having suffered a stroke. The drug, used in humans to treat cutaneous T-cell lymphoma, has been proved to mitigate brain injuries and help in restoring brain tissue. Ischemic stroke...
Tag: <span>Anti cancer</span>
Post
Scientists develop a new type of anti-cancer agent
by Center for Research in Biological Chemistry and Molecular Materials (CiQUS) Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Many cancer therapies, in addition to producing numerous side effects, fail to achieve complete tumor remission, partly due to...
Post
Emerging Anti-Cancer mRNA Vaccines in the Pipeline
Patricia Weiser, Pharm.D. Vaccine technology is rapidly growing in the pharmaceutical industry, with therapy options expanding in response to areas of clinical need. One area of focus is the development of vaccines targeting cancer. Cancer vaccines generally fall into two categories: preventive and active treatment. Preventive cancer vaccines are currently more established and focus on...
Post
Drug mechanism opens door for new anti-cancer immunotherapies
by King’s College London Credit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immune cell function, that could be exploited using new anti-cancer immunotherapies. New research has revealed how a class of new medicines used to treat the blood cancer chronic lymphocytic leukemia...